Subtopic Deep Dive

Prenylated Flavonoids Structure-Activity Relationship
Research Guide

What is Prenylated Flavonoids Structure-Activity Relationship?

Prenylated Flavonoids Structure-Activity Relationship (SAR) examines how prenyl groups and substituents on flavonoid scaffolds modulate their pharmacological potencies through synthesis, QSAR modeling, and bioassays.

Researchers correlate prenyl chain positions, lengths, and flavonoid core modifications with bioactivities like antiviral, antidiabetic, and antibacterial effects. Over 20 papers since 2008 detail SAR patterns, including QSAR models and SVM classifications (Dong et al., 2008; Mukne et al., 2011). Comprehensive reviews summarize 100+ prenylated flavonoids from natural sources (Shi et al., 2021; Lv et al., 2023).

Curated Papers

Key Challenges

Why It Matters

SAR insights from prenylated flavonoids enable rational design of derivatives with enhanced antiviral potency, as Badshah et al. (2021, 374 citations) link prenyl substitutions to SARS-CoV-2 inhibition. Antidiabetic applications arise from structure-specific α-glucosidase inhibition detailed by Shamsudin et al. (2022, 161 citations), guiding drug leads for type 2 diabetes. Antibacterial SAR against MRSA drives synthesis of optimized isoflavones (Mukne et al., 2011, 69 citations), addressing antibiotic resistance in clinical settings.

Key Research Challenges

Prenyl Position Optimization

Determining exact prenyl attachment sites for maximal bioactivity remains challenging due to steric and electronic effects varying by target. Shi et al. (2021, 93 citations) review synthetic modifications but note inconsistent activity gains. QSAR models struggle with sparse natural product data (Dong et al., 2008).

Bioavailability Enhancement

Prenyl groups improve lipophilicity but often reduce aqueous solubility, limiting in vivo efficacy. Lv et al. (2023, 73 citations) highlight poor pharmacokinetics in pharmacological assays. Balancing activity and ADME properties requires advanced modeling (Alhassan et al., 2014).

Scalable Synthesis Barriers

Regioselective prenylation of flavonoids demands multi-step synthesis with low yields from natural extracts. Reviews by Shi et al. (2021) and Alhassan et al. (2014) emphasize need for biomimetic methods. Structural complexity hinders high-throughput SAR screening.

Essential Papers

Antiviral activities of flavonoids

Syed Lal Badshah, Shah Faisal, Akhtar Muhammad et al. · 2021 · Biomedicine & Pharmacotherapy · 374 citations

Flavonoids as Antidiabetic and Anti-Inflammatory Agents: A Review on Structural Activity Relationship-Based Studies and Meta-Analysis

Nur Farisya Shamsudin, Qamar Uddin Ahmed, Syed Mahmood et al. · 2022 · International Journal of Molecular Sciences · 161 citations

Flavonoids are a group of naturally occurring polyphenolic secondary metabolites which have been reported to demonstrate a wide range of pharmacological properties, most importantly, antidiabetic a...

A comprehensive review: Biological activity, modification and synthetic methodologies of prenylated flavonoids

Shao-Chun Shi, Jichong Li, Xuemei Zhao et al. · 2021 · Phytochemistry · 93 citations

Phytochemistry and pharmacology of natural prenylated flavonoids

Huawei Lv, Qiao-Liang Wang, Meng Luo et al. · 2023 · Archives of Pharmacal Research · 73 citations

Structure pre-requisites for isoflavones as effective antibacterial agents

AlkaP Mukne, Vivek Viswanathan, AvinashG Phadatare · 2011 · Pharmacognosy Reviews/Bioinformatics Trends/Pharmacognosy review · 69 citations

Recent reports reveal that there is increasing incidence of infections of multidrug-resistant bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enteroc...

Advances on Antiviral Activity of Morus spp. Plant Extracts: Human Coronavirus and Virus-Related Respiratory Tract Infections in the Spotlight

Inès Thabti, Quentin Albert, Stéphanie Philippot et al. · 2020 · Molecules · 66 citations

(1) Background: Viral respiratory infections cause life-threatening diseases in millions of people worldwide every year. Human coronavirus and several picornaviruses are responsible for worldwide e...

A natural chalcone induces apoptosis in lung cancer cells: 3D-QSAR, docking and an in vivo/vitro assay

Gang Chen, Di Zhou, Xue-Zheng Li et al. · 2017 · Scientific Reports · 66 citations

Abstract This study was to study the antitumor effect of lonchocarpin ( 34 ) from traditional herbal medicine Pongamia pinnata (L.) Pierre and to reveal the underlying mechanism. The cytotoxic acti...

Reading Guide

Foundational Papers

Start with Mukne et al. (2011, 69 citations) for isoflavone antibacterial SAR prerequisites; Alhassan et al. (2014, 62 citations) introduces prenylation biosynthesis; Dong et al. (2008, 29 citations) details SVM-QSAR for vasorelaxants.

Recent Advances

Badshah et al. (2021, 374 citations) for antiviral SAR; Shamsudin et al. (2022, 161 citations) antidiabetic meta-analysis; Lv et al. (2023, 73 citations) pharmacology compendium.

Core Methods

QSAR (SVM, 3D models), regioselective prenylation synthesis, docking simulations, bioassays (MIC, α-glucosidase inhibition), supported by HPLC isolation from Morus/Sophora.

How PapersFlow Helps You Research Prenylated Flavonoids Structure-Activity Relationship

Discover & Search

Research Agent uses searchPapers('prenylated flavonoids SAR QSAR antiviral') to retrieve Badshah et al. (2021, 374 citations), then citationGraph reveals 50+ citing works on prenyl modifications; findSimilarPapers expands to antidiabetic SAR from Shamsudin et al. (2022); exaSearch uncovers niche synthesis protocols.

Analyze & Verify

Analysis Agent applies readPaperContent on Shi et al. (2021) to extract 93 prenylated structures, runPythonAnalysis with pandas to compute QSAR descriptors (e.g., logP correlations), and verifyResponse via CoVe with GRADE scoring confirms SAR claims against Mukne et al. (2011) antibacterial data; statistical verification tests prenyl length-activity trends.

Synthesize & Write

Synthesis Agent detects gaps in antiviral SAR coverage post-Badshah et al. (2021), flags contradictions between prenyl effects in Lv et al. (2023) vs. Alhassan et al. (2014); Writing Agent uses latexEditText for SAR tables, latexSyncCitations integrates 20 papers, latexCompile generates polished review, exportMermaid diagrams prenyl-flavonoid activity maps.

Use Cases

"Run QSAR regression on prenyl flavonoid antibacterial MIC data from Mukne et al. 2011"

Research Agent → searchPapers → Analysis Agent → readPaperContent + runPythonAnalysis (scikit-learn linear regression on extracted MICs/logP) → CSV export of R²=0.82 model predicting isoflavone potency.

"Draft LaTeX section on antidiabetic SAR from Shamsudin et al. 2022 with figures"

Synthesis Agent → gap detection → Writing Agent → latexEditText (SAR summary) → latexGenerateFigure (activity heatmaps) → latexSyncCitations (10 refs) → latexCompile → PDF with prenyl substitution table.

"Find GitHub repos with prenylated flavonoid synthesis code linked to Dong et al. 2008"

Research Agent → paperExtractUrls (Dong 2008) → Code Discovery → paperFindGithubRepo (SVM QSAR scripts) → githubRepoInspect → runnable Jupyter notebook for vasorelaxant predictions.

Automated Workflows

Deep Research workflow scans 50+ papers via searchPapers on 'prenylated flavonoids SAR', structures report with SAR tables by activity (antiviral from Badshah 2021 → antidiabetic Shamsudin 2022). DeepScan's 7-step chain verifies QSAR models: readPaperContent → runPythonAnalysis → CoVe checkpoints against Lv et al. (2023). Theorizer generates hypotheses on prenyl chain length for antibacterial optimization from Mukne et al. (2011) data.

Try Doxa for Prenylated Flavonoids Structure-Activity Relationship Research

Frequently Asked Questions

What defines prenylated flavonoids SAR?

SAR studies link prenyl group positions (e.g., A-ring vs. B-ring) and lengths to bioactivity enhancements in antiviral, antidiabetic, and antibacterial assays (Badshah et al., 2021; Shamsudin et al., 2022).

What are key methods in prenylated flavonoids SAR?

Methods include QSAR modeling (SVM in Dong et al., 2008), molecular docking, and synthesis of analogs; bioassays test against α-glucosidase or MRSA (Mukne et al., 2011; Shi et al., 2021).

What are the most cited papers?

Badshah et al. (2021, 374 citations) on antiviral flavonoids; Shamsudin et al. (2022, 161 citations) on antidiabetic SAR; Shi et al. (2021, 93 citations) reviewing prenylated flavonoid synthesis.

What open problems exist?

Challenges include regioselective prenylation synthesis, improving bioavailability, and integrating multi-target SAR models; sparse in vivo data limits translation (Lv et al., 2023; Alhassan et al., 2014).